July 14, 2026

Beacon Angels members conducted the following new business at its meeting on Tuesday, July 14, 2026:

We entertained new funding proposals from the following companies:

• Restoration Medicine, transforming pelvic health care with telehealth.
• FIND Neuro, building an AI clinical platform to provide epilepsy surgery planning to neurosurgeons.

We heard an update from a Beacon Angels portfolio company:

• NF2 Therapeutics, developing therapies for neurofibromatosis 2 related schwannomatosis (NF2).

We discussed updates on multiple funding rounds, by Series number:

• Pending
  • S146B – AOA Dx
  • S156 – NIRA

• Members provided an update on companies in due diligence:

• Augmenteum, developing and selling patented, active optics to replace bulky lens systems with compact, solid-state imaging for drones and other precision devices.
• Highland Instruments, developing a noninvasive brain stimulation platform to help patients overcome addiction, chronic pain, and movement disorders.